Clearpoint Neuro Inc (CLPT)

When (CLPT) Moves Investors should Listen - Stock Traders Daily

Stock Traders Daily

ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1 - Barchart

Barchart

ClearPoint Neuro to Announce First Quarter 2022 Results May 11, 2022 - Barchart

Barchart

Recruitment of Glioblastoma Patients to the CLS-sponsored Clinical Study at Skåne University Hospital is now ... - Marketscreener.com

Marketscreener.com

Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way? - Yahoo Movies UK

Yahoo Movies UK

ClearPoint Neuro congratulates Aspen Neuroscience on use of Navigation System - TipRanks.com - TipRanks

TipRanks

ClearPoint Neuro: Solid Progress Still Not Reflected In The Share Price (NASDAQ:CLPT) - Seeking Alpha

Seeking Alpha

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous ... - BioSpace

BioSpace

How Does ClearPoint Neuro's (NASDAQ:CLPT) CEO Salary Compare to Peers? - Yahoo Movies UK

Yahoo Movies UK

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All ... - GlobeNewswire

GlobeNewswire

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All ... - Yahoo Finance

Yahoo Finance

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous ... - StreetInsider.com

StreetInsider.com

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous ... - Marketscreener.com

Marketscreener.com

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous ... - StockTitan

StockTitan

CLS receives additional order for ClearPoint Prism products corresponding to approximately SEK 7.5 million - Marketscreener.com

Marketscreener.com

Clinical Laserthermia Systems AB Receives Additional Order for Clearpoint Prism Products Associated to ... - Marketscreener.com

Marketscreener.com

Can you now get a good deal on ClearPoint Neuro Inc's shares? – US Post News - US Post News

US Post News

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 6.3% in May - Defense World

Defense World

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 6.3% in May - Defense World

Defense World

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 6.3% in May - MarketBeat

MarketBeat

Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way? - Yahoo Movies UK

Yahoo Movies UK

ClearPoint's (CLPT) New Products to Boost Neurosurgical Segment - MSN

MSN

BioStock: CLS' partner initiates full market release in the US - Marketscreener.com

Marketscreener.com

News - BioStock - Connecting Innovation and Capital

BioStock - Connecting Innovation and Capital

CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S - Marketscreener.com

Marketscreener.com

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 5.9% in May - Defense World

Defense World

Hertz Global Holdings, Inc. (NASDAQ:HTZWW) Short Interest Down 5.9% in May - Defense World

Defense World

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 5.9% in May - MarketBeat

MarketBeat

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 5.9% in May - MarketBeat

MarketBeat

ClearPoint's (CLPT) New Products to Boost Neurosurgical Segment - Yahoo Finance

Yahoo Finance

ClearPoint's (CLPT) New Products to Boost Neurosurgical Segment - Zacks Investment Research

Zacks Investment Research

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 5.9% in May - MarketBeat

MarketBeat

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy ... - GlobeNewswire

GlobeNewswire

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

GlobeNewswire Inc.

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy ... - Yahoo Finance

Yahoo Finance

News - BioStock - Connecting Innovation and Capital

BioStock - Connecting Innovation and Capital

Does ClearPoint Neuro (CLPT) Have the Potential to Rally 81.49% as Wall Street Analysts Expect? - MSN

MSN

Does ClearPoint Neuro (CLPT) Have the Potential to Rally 81.49% as Wall Street Analysts Expect? - MSN

MSN

Does ClearPoint Neuro (CLPT) Have the Potential to Rally 81.49% as Wall Street Analysts Expect? - Zacks Investment Research

Zacks Investment Research

Does ClearPoint Neuro (CLPT) Have the Potential to Rally 81.49% as Wall Street Analysts Expect? - Yahoo Canada Finance

Yahoo Canada Finance

ClearPoint Neuro Inc (CLPT) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

The InvestChronicle

ClearPoint Neuro Inc (CLPT) Clearly Signals Buy-Into the Stock: Don't ignore the signals – Sete News - SETE News

SETE News

When (CLPT) Moves Investors should Listen - Stock Traders Daily

Stock Traders Daily

ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Sport Australia

Yahoo Sport Australia

Clinical Laserthermia Systems Receives Order From ClearPoint Neuro - Marketscreener.com

Marketscreener.com

ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo New Zealand News

Yahoo New Zealand News

Analyzing RenovaCare (OTCMKTS:RCAR) and ClearPoint Neuro (NASDAQ:CLPT) - Defense World

Defense World

ClearPoint Neuro Stockholders Approve Key Proposals and Directors - TipRanks.com - TipRanks

TipRanks

Objective long/short (CLPT) Report - Stock Traders Daily

Stock Traders Daily

Wall Street Analysts Predict a 70.65% Upside in ClearPoint Neuro (CLPT): Here's What You Should Know - Yahoo Finance UK

Yahoo Finance UK